Current status: New calls for applications to be announced soon

Mass immunisation campaigns have been successful in eradicating measles entirely. North and South America have been declared free of endemic measles and African countries like Tanzania reach a high percentage of the population with the first vaccination shot. With less strict vaccination policies, European countries are much less successful in their immunisation schedules against measles. In Europe, vaccination rates are poorer and critics of measles vaccination are on the advance. The project aims to investigate the importance of comprehensive immunisation, national health care policies and individual responsibility.

The project considers health care policies in Germany as well as the East African region with Tanzania and Malawi. Which are the reasons of general confusion about risks and benefits of vaccines, especially regarding unintended side-effects? Which measures are pursued around the globe to achieve sufficiently high measles immunisation rates?

While Tanzania is doing extraordinarily well in pursuing the goal of controlling measles and improving the administration of vaccines from its’ logistic transport, cool chain and cooperation with local communities within the districts, Malawi’s health sector falls behind with measles vaccination rates being much lower than in Tanzania and Malawi’s shortage of health care personnel being the most severe in the region.

Thus the second focus will be on the the differences within the region: How come that the health systems’ achievements vary so much from country to country?  Which are the reasons that - while sharing a border in the East African region - the outcome in vaccination administration in those two countries differ so notably?

By comparing the situation to the one on a different continent and by exploring the several historical and political factors that contribute to the current situation in Germany, the project aims to draw attention towards the battle against vaccine-preventable infectious diseases.

Project links

Project information

  • Locations
    Malawi , Tanzania, Germany
  • Duration
    9 months
  • Release date
    October 2017
  • Budget
    € 15065